Anúncio
Anúncio

NVS

NVS logo

Novartis AG

137.86
USD
Patrocinado
-0.86
-0.62%
31 de dez., 16:00 UTC -5
Encerrado
exchange

Pós-Mercado

137.84

-0.02
-0.02%

Relatórios de Lucros NVS

Rácio de surpresa positiva

NVS separação 24 de 39 últimas estimativas.

62%

Próximo Relatório

Data do Próximo Relatório
04 de fev. de 2026
Estimate for Q4 25 (Revenue/ EPS)
$14.11B
/
$1.98
Mudanças implicadas de Q3 25 (Revenue/ EPS)
+1.41%
/
-12.00%
Mudanças implicadas de Q4 24 (Revenue/ EPS)
+7.24%
/
--

Novartis AG earnings per share and revenue

On 28 de out. de 2025, NVS reported earnings of 2.25 USD per share (EPS) for Q3 25, missing the estimate of 2.29 USD, resulting in a -2.11% surprise. Revenue reached 13.91 bilhão, compared to an expected 14.31 bilhão, with a -2.81% difference. The market reacted with a -4.42% price change (close before vs. close after earnings).
Looking ahead to Q4 25, 8 analistas forecast an EPS of 1.98 USD, with revenue projected to reach 14.11 bilhão USD, implying an diminuir of -12.00% EPS, and aumentar of 1.41% in Revenue from the last quarter.
FAQ
For Q3 2025, Novartis AG reported EPS of $2.25, missing estimates by -2.11%, and revenue of $13.91B, -2.81% below expectations.
The stock price moved down -4.42%, changed from $129.14 before the earnings release to $123.43 the day after.
The next earning report is scheduled for 04 de fev. de 2026.
Based on 8 analistas, Novartis AG is expected to report EPS of $1.98 and revenue of $14.11B for Q4 2025.
Verificar FXEmpire's Earnings Calendar for today's list of reporting companies.
Anúncio